noscript

News Hot Pursuit

 
Divi's Lab spurts after Telangana facility clears USFDA inspection
15-Nov-19   15:03 Hrs IST
The counter clocked volume of 68,000 shares, a 4 times surge over two-week average daily volume of 17,000 shares.

Divi's Laboratories on Friday announced that unit-I facility at Lingojigudem, in Telangana was inspected by the USFDA from the 11th to 15th November 2019. This inspection was a general cGMP inspection by the USFDA. The inspection has been concluded with no 483 observations. The announcement was made during market hours today, 15 November 2019.

On consolidated basis, the company's net profit declined 11.6% to Rs 356.78 crore in Q2 September 2019 over Q2 September 2018. Net sales rose 9.2% to Rs 1445.57 crore on YoY basis in Q2 September 2019.

The stock is trading near its 52-week high of Rs 1776.15 registered on 27 October 2019. Divi's Lab has surged 14.14% in last three months compared to a 0.23% rise in Nifty Pharma index.

Divis Laboratories is engaged in the manufacture of active pharmaceutical ingredients (API's), intermediates and nutraceutical ingredients with predominance in exports.

Powered by Capital Market - Live News

Attention Investors:
KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. Prevent Unauthorized Transactions in your Demat account\Trading account: Update your Mobile Number with your Depository Participant\Exchange. Receive alerts on your Registered Mobile for all debit and other important transactions in your Demat account\Trading account directly from Depository\Exchange on the same day.........issued in the interest of investors.
Disclosure of Proprietary Account Trading by Members to Clients
Proprietary Trading Disclosure:In terms of provisions of the Rules, Bye-Laws and Business Rules of the Exchange and with reference to circular MCX/T&S/147/2016 dated May 17, 2016 regarding Disclosure of Proprietary Account Trading by broker to client.,Pursuant to SEBI Circular Number SEBI/MRD/SEC/Cir-42/2003 dated November 19, 2003 & SEBI/HO/CDMRD/DMP/CIR/P/2016/49 dated April 25, 2016 GOODWILL WEALTH MANAGEMENT PVT LTD. Discloses to its clients about its policies on proprietary trades. Goodwill does proprietary trading in the derivatives segment at MCX respectively.GOODWILL – SEBI Reg No. INZ000049087
Copyright © 2016 All rights Reserved GOODWILL
Designed, Developed and content powered by CMOTS Infotech ( ISO 9001:2015 certified )
Filing complaints on SEBI Complaint Redress System (SCORES)
– Easy & quick
  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name, PAN, Address, Mobile Number, E-mail ID.
  • Benefits:
    • Effective communication
    • Speedy redressal of the grievances.
You can file complaints on SCORES through https://scores.gov.in/scores/Welcome.html